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Abstract: The investigation of carbonic anhydrase and paraoxonase enzyme inhibition properties of water-soluble zinc and gallium
phthalocyanine complexes (1 and 2) are reported for the first time. The binding of p-sulfonylphenoxy moieties to the phthalocyanine
structure favors excellent solubilities in water, as well as providing an inhibition effect on carbonic anhydrase (CA) I and II isoenzymes
and paraoxonase (PON1) enzyme. According to biological activity results, both complexes inhibited hCA I, hCA II, and PON1. Whereas
1 and 2 showed moderate hCA I and hCA II (off-target cytosolic isoforms) inhibitory activity (Ki values of 26.09 µM and 43.11 µM
for hCA I and 30.95 µM and 33.19 µM for hCA II, respectively), they exhibited strong PON1 (associated with high-density lipoprotein
[HDL]) inhibitory activity (Ki values of 0.37 µM and 0.27 µM, respectively). The inhibition kinetics were analyzed by Lineweaver–Burk
double reciprocal plots. It revealed that 1 and 2 were noncompetitive inhibitors against PON1, hCA I, and hCA II. These complexes can
be more advantageous than other synthetic CA and PON inhibitors due to their water solubility. Docking studies were carried out to
examine the interactions between hCA I, hCA II, and PON1 inhibitors and metal complexes at a molecular level and to predict binding
energies.
Key words: Phthalocyanine, sulfonated, water-soluble, paraoxonase, carbonic anhydrase, enzyme inhibition, molecular docking

1. Introduction
Phthalocyanines (Pcs), an important family of porphyrinoid complexes, have many applications such as gas sensors [1],
solar cells [2], liquid crystals phases [3,4], electrochromic materials [5], and photosensitizer [6–9] in photodynamic
therapy (PDT). For these applications, the photophysical and photochemical features of phthalocyanines can be finetuned by the introduction of various substituent groups. It is also known that the physical and chemical properties of
the complex depend significantly on the nature of the metal atom coordinated to the phthalocyanine ring [8,10,11]. The
lack of water solubility of phthalocyanines limits their use in many areas. Also, water solubility is very important for
cancer treatments because the complexes are injected into the patient’s bloodstream with a hydrophilic system [12]. Watersoluble phthalocyanines continue to attract attention to their interactions with DNA and their ability to trigger DNA
photodamage by accumulating in many cancer cells. Sulfonate, carboxylate, and phosphorus groups can be used from
anionic substituents to the macrocyclic ring by various intermediates or directly attached to the phthalocyanine complexes.
In particular, the binding of sulfonic acid groups to the phthalocyanine ring has two important effects: they increase the
effectiveness of their antitumor properties [13], and by inducing the repulsion of phthalocyanine rings, they become
water-soluble as monomers [9,12,14]. Also, in the literature, gallium and zinc metal complexes of the phthalocyanines are
examined due to their superior antitumor properties [13]. Thus, these phthalocyanines are beneficial to PDT and various
biological applications.
Carbonic anhydrase (CA) isoenzymes are metalloenzymes that catalyze a very easy reaction: the hydration of CO2 to
bicarbonate and H+ [15–17]. This key reaction plays a significant role in more pathological and physiological mechanisms
associated with ion transport, pH control, and fluid secretion [18]. The inhibition of these isoenzymes is the main goal
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correlated with the treatment of diverse diseases such as obesity, glaucoma, and epilepsy. More recently, CA inhibition
was validated as a novel approach to fighting metastases and tumors. Paraoxonase, which has an important role in living
metabolism, is a calcium-dependent enzyme and is also an organophosphate hydrolyzer. These enzymes can hydrolyze
aromatic carboxyl esters such as phenylacetate and various lactones. The name “PON” is derived from paraoxon, a
common in vitro substrate. Paraoxonase 1 (PON1), which is associated with high-density lipoprotein (HDL) with 355
amino acids, is the most studied member of the mammalian enzyme family. PON1 is considered an important enzyme for
two main reasons in metabolism: (i) it protects the system against the neurotoxicity of organophosphates and (ii) oxidizing
lipid levels interfere with the onset of atherosclerosis, thus preventing oxidation of low-density lipoproteins, so the activity
of PON 1 is considered a risk for atherosclerosis.
Taking these properties into consideration, we focused on water-soluble complexes as a strategy to explain Pcs in
conjunction with the sulfonic acid group to study enzyme inhibition, chemical interactions, and theoretical properties.
In this regard, water-soluble sulfonated zinc and gallium phthalocyanine complexes (1 and 2) were synthesized and their
inhibition potential of hCA I and II isoenzymes and paraoxonase enzyme were investigated to give direction for further
studies. Also, metal effects on carbonic anhydrase and paraoxonase inhibition activity were examined. To the best of
our knowledge, even though there are some studies in the literature in which phthalocyanines are evaluated as carbonic
anhydrase and α‐glucosidase enzyme inhibitors [19–22], carbonic anhydrase and paraoxonase inhibition activity of
anionic water-soluble phthalocyanines has not been reported. Consequently, this is the first study including the evaluation
of anionic water-soluble phthalocyanines bearing Ga and Zn metals and the sulfonic acid group as both potential carbonic
anhydrase and paraoxonase enzyme inhibitors. Furthermore, molecular docking studies were also applied for a better
understanding of the structural and binding profiles of synthesized complexes at the active sites of target enzymes.
2. Experimental design
Details on equipment, materials, enzyme inhibition, and molecular docking parameters are supplied as Supporting
Information. Water-soluble zinc and gallium phthalocyanine complexes (1 and 2) were prepared according to the reported
procedure [14,23]. Biological activity assays and IC50 graphs are provided in Supporting Information.
3. Results and discussion
Figure 1 shows the molecular structure of nonperipherally substituted sulfonated zinc and gallium phthalocyanine
complexes (1 and 2).
The solution spectra show a spectral characteristic indicating D4h symmetry, which is typical for Pc complexes [24]. The
absorption peak in the near-UV region is the B-band or Soret band that is attributed to the a2u→e*g transition; a further
band in the visible region is related to the Q-band caused by the p–p* transition a1u→e*g. It can be stated that there are
some vibrational bands at relatively shorter wavelengths that are a standard property of metallophthalocyanines [25]. The
UV-vis absorption spectra of nonperipherally substituted phthalocyanine complexes in DMSO shows two main peaks, the
characteristic ligand centered π–π* transitions of a monomeric zinc and gallium phthalocyanine derivatives (1 and 2) with
Q-band maxima at 695 and 711 nm, respectively (Figure 2) [14,23,26].
The CA I and CA II inhibitory activities of the synthesized complexes were determined by hydratase activity (used
carbon dioxide as a substrate) and esterase activity (used 4-nitrophenyl-acetate [NPA] as a substrate) assays to calculate

Figure 1. Molecular structure of water-soluble sulfonated zinc and gallium phthalocyanine
complexes.
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the inhibition constants (Ki). Ki values were calculated from the Lineweaver–Burk graphs (Figure 3). The Ki values of the
synthesized compounds 1–2 against PON1, hCA I, and hCA II isoforms are given in Table 1. Complexes 1 and 2 inhibited
the cytosolic isoforms hCA I and hCA II in the micromolar range (Ki values of 26.09 µM and 43.11 µM for hCA I and
30.95 µM and 33.19 µM for hCA II, respectively). Complex 1, which included Zn metal, had higher inhibitory activity
against both hCA I and hCA II with the Ki of 26.09 µM and 30.95 µM, respectively than complex 2 containing Ga metal
(Ki values of 43.11 µM against hCA I and 33.19 µM against hCA II). According to these results, it could be considered that

Figure 2. Absorption spectra of water-soluble zinc and gallium
phthalocyanine complexes (1 and 2) in DMSO (~ 10 × 10–6
mol dm–3).

Figure 3. Lineweaver–Burk graphs of hCA I and hCA II isoenzymes for zinc and gallium phthalocyanine complexes (1 and 2).
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the atomic diameter of the Zn metal is larger than Ga; thus, the Zn complex is bulkier than the Ga complex. Their different
steric effects could change the inhibitory activity because of an entrance of the active site cavity and the van der Waals
interactions with amino acid residues.
Acetazolamide (AAZ) is one of the best-known CAIs and is also used as a standard in CA assays [27]. Whereas
complexes 1 and 2 showed much weaker inhibitory activity against hCA I and hCA II than AAZ (Ki of 250 nM and 12.1
nM against hCA I and hCA II, respectively) [28,29], they exhibited higher hCA I and II inhibitory activity than some
synthesized compounds (Ki or IC50 values ranging between 75 µM and 620 µM against hCA I, between 126 µM and 427
µM against hCA II) reported as CAIs in the literature [30–33].
The sulphonamides (known as strong CAIs) bind in the deprotonated form to the catalytically critical Zn (II) ion in the
enzyme active site [34,35], also contributing an extensive hydrogen bond and van der Waals interactions with amino acid
residues of the enzyme active site, as reported in X-ray crystallographic studies of enzyme-inhibitor complexes [36]. We
consider that the –SO3H moieties of the synthesized complexes can interact with Zn (II) ion and form the hydrogen bonds
with amino acid residues in the enzyme active sites.
On the other hand, the in vitro inhibition effects of synthesized complexes on paraoxonase 1 (PON1) were investigated
using paraoxon as a substrate. Both complex 1 and 2 inhibited PON1 (associated with HDL) with Ki of 0.37 µM and 0.27
µM, respectively, as noncompetitive inhibitors (Figure 4). These results demonstrated that complex 1 and 2 have a much
stronger PON1 inhibitory activity than the reported PON1 inhibitors (Ki or IC50 values ranging between 35 µM and 550
µM) in the literature [37–39]. Besides, the changing metals and their atomic diameters have not shown a significant effect
on PON1 inhibition.
3.1. Molecular docking studies
Docking calculations were carried out using the HEX 8.0.0 program [40]. This docking simulation program has allowed
the calculation of drug candidate molecules for high atomic weight with a metal center. Docking calculation parameters are
correlation type, compute device, FFT mode, and sampling method. These parameters are shape only, CPU, 3D, and range
angles, respectively. Grid parameters are solution-100 and step size-(5.5, 5.5, 2.8). Docking simulations for investigated
complexes were implemented against 4WR7, 5AML, and 1V04 target proteins representing hCA I, hCA II, and PON1
enzymes, respectively. 4WR7 is the crystal structure of human carbonic anhydrase isozyme I with 2,3,5,6-tetrafluoro4-(propylthio) benzenesulfonamide. CA is an enzyme that catalyzes reversible carbon dioxide hydration. It is a
metalloenzyme that ensures the regulation of acid-base balance and ion transport in all tissues and organs. It is known that
Table 1. Ki values of complex 1 and 2 against hCA I, hCA II and PON1.
Comp.

Ki (µM) for
hCA I

Inhibition type

Ki (µM) for
hCA II

Inhibition type

Ki (µM) for
PON1

Inhibition type

1

26.09

Noncompetitive

30.95

Noncompetitive

0.37

Noncompetitive

2

43.11

Noncompetitive

33.19

Noncompetitive

0.27

Noncompetitive

Figure 4. Lineweaver–Burk graphs of paraoxonase1 enzyme for complexes (1 and 2).
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increased levels of different CAs are associated with various diseases such as epilepsy and cancer. Since the enthalpy and
entropy distribution range of this protein is quite wide, it has a greater entropy contribution to the binding affinity during
simulation than enthalpy [41]. 5AML is the three-dimensional structure of human carbonic anhydrase II in complex with
2-(but-2-yn-1-ylsulfamoyl)-4-sulfamoylbenzoic acid. The 5AML target protein has selectivity corresponding to some CA
isoforms with medical applications. This protein has a high potential modulus as it contains aliphatic, alkenyl, aralkyl
groups, and saccharin derivative substituents [42].
PON1 is a glycoprotein Ca2+-dependent ester hydrolase, which is synthesized in the liver and is found in HDL in human
serum, consisting of 355 amino acids [43]. PON1 is an enzyme with paraoxonase, arylesterase, and lactonase activities
that can react with a wide variety of substrates [44]. The three-dimensional structure of a hybrid mammalian recombinant
PON1 variant obtained by directed evolution (rePON1) was recently determined providing the first structural information
about this hydrolase family, and this structure was named 1V04 [45]. The biological activity of synthesized zinc and
gallium phthalocyanine complexes (1) and (2) against hCA I, hCA II, and PON enzymes was attempted to be elucidated by
molecular simulation method. Secondary chemical interactions between the amino acid residues of the 4WR7, 5AML, and
1V04 target proteins and the complexes studied were also investigated. In the coupling studies, the estimated free energy
of the binding values and the binding modes of the target proteins and metal complexes is given in Table 2 and Figure 5,
respectively. According to the docking results in Table 2, the inhibition activities between the complexes and the target
proteins, the gallium complex (2) is greater than the inhibition activity of the zinc complex (1). Gallium complex is located
in the symmetry cavity of the 4WR7 target protein. Since the gallium complex contains chlorine atoms, it contains a halogen
bond in the secondary chemical interaction type. The halogen bond occurs between the chlorine atom bound to the gallium
metal and the Gln92 amino acid residue. Also, the gallium complex is in polar interaction with the target protein.
Table 2. The docking results between complexes (1) and (2) and the target proteins.
4WR7
(hCA I)

(1)

(2)

Binding energy (kcal/mol)

–4.20

–4.88

Type of interaction

H-bond

H-bond
Halogen
Polar

Binding site

His119

His94, Thr199
Gln92
Leu198

5AML
(hCA II)

(1)

(2)

Binding energy (kcal/mol)

–4.07

–4.13

Type of interaction

H-bond

H-bond
Halogen

Binding site

His94

His94, Thr199
His200, Asn62

1V04
(PON1)

(1)

(2)

Binding Energy (kcal/mol)

–5.25

–5.94

Type of interaction

H-bond
Polar
pi-pi

H-bond
Halogen
Polar
pi-pi

Binding site

ASP54
GLU53, ASP54, ASN227
HIS115, TYR236

ASP269
HIS115, LEU240, LEU267, ILE291
HIS115, ASN168, ASP183, ASN224
HIS115, HIS285, PHE292
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Figure 5. The binding modes between investigated phthalocyanine metal complexes and the determined target
proteins.

The increase in the number of secondary chemical interactions between this complex and target proteins may have
increased the estimated binding energy. It is clear from the results that in the gallium phthalocyanine complex there are
two H-bonds between the His94 and Thr199 amino acid residues of the 4WR7 target protein. This is seen as an H-bond
in the zinc complex. The H-bond appears between the zinc phthalocyanine complex and the His199 amino acid residue of
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the 4WR7 target protein. Both metallophthalocyanine complexes show a similar trend with the 5AML target protein and
the 4WR7 target protein. However, in contrast to the interaction of complexes with 5AML target protein, polar interaction
is unlike any other.
Zinc and gallium complexes are in a stronger interaction with the 1V04 target protein, which represents the PON1
enzyme, compared to other enzymes. The types of secondary chemical interactions of the compounds with the 1V04 target
protein are greater, as seen in Table 2. In the gallium metal-centered complex, unlike in the zinc complex, the halogen bond
with the HIS115, LEU240, LEU267, and ILE291 amino acid residues draws attention. The binding energies obtained from
the docking results show that the calculated energy values are in a trend parallel with enzyme activities.
As a result, simulation results tend to be similar to experimental inhibition activity. Docking studies are thought to be
very important for understanding the chemical interaction mechanism in the inhibition effect.
4. Conclusion
In this paper, the investigation of carbonic anhydrase and paraoxonase enzyme inhibition properties of water-soluble
sulfonated zinc and gallium phthalocyanines are reported for the first time. The results showed that complex 1 and 2
inhibited the cytosolic isoforms hCA I and hCA II (off-target cytosolic isoforms) in the micromolar range (Ki values of
26.09 µM and 43.11 µM for hCA I and 30.95 µM and 33.19 µM for hCA II, respectively). Moreover, they inhibited PON1
(associated with HDL) with Ki of 0.37 µM and 0.27 µM, respectively. The inhibition kinetics was analyzed by Lineweaver–
Burk double reciprocal plots. The analysis revealed that complex 1 and 2 were noncompetitive inhibitors against PON1,
hCA I, and hCA II. Whereas complex 1 and 2 showed moderate hCA I and hCA II inhibitory activity, they exhibited
strong PON1 inhibitory activity. Furthermore, the changing metals (Zn and Ga) and their atomic diameters affected the
CA inhibitory activity, while they did not show a significant effect on PON1. These complexes can be more preferable than
other synthetic CA and PON inhibitors due to their high water solubility. Finally, the inhibition efficacy between zinc and
gallium complexes and hCA I and hCA II enzymes has been studied in detail with molecular simulation, and experimental
data and docking results are highly compatible.
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SUPPORTING INFORMATION

1. Materials
All reagents and solvents were of reagent grade quality and were obtained from commercial suppliers. The homogeneity of
the products was tested in each step by TLC. The solvents were stored over molecular sieves. All solvents were dried and
purified.
2. Equipment
IR spectra were recorded on a Thermo Scientific iS10 FT-IR (ATR sampling accessory) spectrophotometer and electronic
spectra on a Shimadzu UV-2450 UV-vis spectrophotometer. 1H-NMR and 13C-NMR spectra were recorded on Agilent
VNMRS 300 MHz and the spectrum was referenced internally by using the residual solvent resonances; chemical shifts
were reported relative to Me4Si as an internal standard. Mass spectra were measured on a Micromass Quatro LC/ULTIMA
LC-MS/MS spectrometer and MALDI-MS of complexes were obtained in dihydroxybenzoic acid as MALDI matrix using
nitrogen laser accumulating 50 laser shots using Bruker Microﬂex LT MALDI-TOF mass spectrometer, Bremen, Germany.
3. Biological activity assays
Preparation of hemolysate and purification from red blood cells
Blood samples (25 mL) from healthy human volunteers were collected. They were centrifuged at 1000 × g for 20 min at 4 ℃
and the supernatant was removed. The packed erythrocytes were washed three times with 0.9% NaCl and then hemolyzed
in cold water. The pH of the hemolysate was adjusted to 8.5 with a solid Tris-base. Twenty-five milliliters of hemolysate
were applied to an affinity column containing Sepharose 4B-ethylene diamine-4-isothiocyanato-benzenesulfonamide [1].
CA isozymes were then eluted with 0.1 M NaCl / 25 mM Na2HPO4 (pH 6.3) and 0.1 M CH3COONa / 0.5 M NaClO4 (pH
5.6), which recovered hCA I and II, respectively.
Hydratase activity assay
CA activity was measured with the Maren method based on the determination of the time required for the pH to
decrease from 10.0 to 7.4 due to CO2 hydration. The assay solution was 0.5 M Na2CO3 / 0.1 M NaHCO3 (pH 10.0); and
phenol red was added as the pH indicator. CO2-hydratase activity (enzyme units [EU]) was calculated by using the equation
t0–tc/tc, where t0 and tc are the times for pH change of the nonenzymatic and the enzymatic reactions, respectively. For the
inhibition studies of complexes, different concentrations of these compounds were added to the enzyme. Activity % values
of CA for different concentrations of each compound were determined by regression analysis using Microsoft Office 2000
Excel. CA enzyme activity without a sample was accepted as 100% activity. For the compounds having an inhibition effect,
the inhibitor concentration causing up to 50% inhibition (IC50 values) was determined from the graphs.
Esterase activity assay
CA activity was assayed by following the change in absorbance at 348 nm of 4-nitrophenyl-acetate (NPA) to
4-nitrophenylate ion over a period of 3 min at 25 °C using a spectrophotometer (Biotek Power Wave XS) according to the
method described in the literature [2]. The inhibitory effects of zinc and gallium complexes (1 and 2) on enzyme activities
were tested under in vitro conditions; Ki values were calculated from Lineweaver–Burk [3] graphs.
Purification of paraoxonase from human serum by hydrophobic interaction chromatography
Human serum was isolated from 40 mL of fresh human blood and added into a dry tube. The blood samples were
centrifuged at 3000 rpm for 15 min and the serum was removed. Firstly, serum paraoxonase was obtained via ammonium
sulphate precipitation (60%–80%). The precipitate was accumulated by centrifugation at 15,000 rpm for 40 min and dissolved
in 100 mM Tris–HCl buffer (pH 8.0). Then, for the purification of human serum paraoxonase, we used hydrophobic
interaction chromatographic gel-(Sepharose 4B, L-tyrosine 1-napthylamine) [4]. The column was equilibrated with 0.1
M of a Na2HPO4 buffer (pH 8.00), including 1 M ammonium sulphate. The paraoxonase was eluted with an ammonium
sulphate gradient using 0.1 M Na2HPO4 buffer with and without ammonium sulphate (pH 8.00).
Paraoxonase enzyme assay
Paraoxonase enzyme activity was quantified spectrophotometrically using paraoxon substrate by the method identified
in Gan et al. [5]. The reaction was determined for 1 min at 37 °C via the appearance of p-nitrophenol at 412 nm in a Biotek
automated recording spectrophotometer. The final substrate concentration during enzyme assay was 2 mM, and all rates
were measured in duplicate and corrected for the nonenzymatic hydrolysis. The paraoxonase enzyme unit was defined as
the quantity of enzyme that hydrolyses 1 µmol of p-nitrophenol. A molar extinction coefficient (ε) of 17,100 M−1cm−1 for
p-nitrophenol at pH 8.0 in 100 mM Tris–base buffer was used for the calculation.
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In vitro kinetic studies
For the kinetic studies of synthesized complexes, different concentrations were added to the enzyme activity. Paraoxonase
activity with compounds was assayed by following the hydration of paraoxon. Activity % values of paraoxonase for five
or more different concentrations of each complex were determined by regression analysis using Microsoft Office 2010
Excel. Control enzyme activity without the complex was 100% and the activity of each compound increased the ratio. For
the compounds having an inhibition effect, the inhibitor concentration causing up to 50% inhibition (IC50 values) was
determined from the graphs.
Total protein determination
Absorbance at 280 nm was used to monitor the protein in the column effluents and ammonium sulphate precipitation.
Quantitative protein determination was achieved by absorbance measurements at 595 nm according to Bradford [6] with
bovine serum albumin as a standard.
SDS polyacrylamide gel electrophoresis
After purification of human paraoxonase1 (hPON1), sodium dodecyl sulphate polyacrylamide gel electrophoresis
(SDS-PAGE) was applied in two different acrylamide concentrations, 10% and 3%, for the running and stacking gel,
respectively, consisting of 0.1% SDS. A 20 mg sample was added to the electrophoresis composition. The gel was kept
overnight in 0.1% Coomassie Brilliant Blue R-250 in 50% methanol and 10% acetic acid, then detained by fast changing
the same solvent, without dye. The electrophoretic figure was photographed; an image of the gel is shown in Figure S1.

Figure S1. SDS-PAGE of human serum paraoxonase1. The pooled fractions from hydrophobic interaction chromatographic were
analyzed by SDS-PAGE (12% and 3%) and revealed by Coomassie Blue staining. Experimental conditions were as described in the
method. Lane 1 contained 5 μL of various molecular mass standards: 3-galactosidase (116.0), bovine serum albumin (66.2), ovalbumin
(45.0), lactate dehydrogenase (35.0), restriction endonuclease (25.0), 3-lactoglobulin (18.4), lysozyme (14.4). Only one protein-staining
band was detectable on Line 2.

4. Preparation of the phthalocyanine complexes
General procedures for phthalocyanine complexes
Reaction: A mixture of 4-(2,3-dicyanophenoxy)benzenesulfonic acid (0.100 g, 0.333 mmol), 0.110 mmol anhydrous metal
salts (ZnCl2, 0.020 g, GaCl3, 0.015 g), and a catalytic amount of DBU (1,8-diazabicyclo[5.4.0]undec-7-ene) in n-pentanol
(2 cm3) was irradiated with a microwave at 145 °C in a sealed glass tube for 25 min under a nitrogen atmosphere. Work up:
After cooling to room temperature, the green mixture was cooled, precipitated by adding hexane, and filtered. Purification:
After being washed with cold ethanol, chloroform, and then with acetone several times, the deep blue-green product was
dissolved in HCl solution (50 mL, 0.8 M), reprecipitated with an excess of acetone, and dried in vacuo at 100 °C. Solubility:
Highly soluble in water and moderately soluble in DMF and DMSO.
Zinc phthalocyanine (1): Yield: 0.065 g. 61%, FTIR, cm–1 3429 (m, SO3H), 3071 (w, C–H), 1583 (m, Ar), 1216 (s,
R–O–Ar), 1209 (m, S=O asym.st), 1122 (s, SO3H), 1032 (s, S=O sym. st.). UV-vis lmax (nm) DMSO: 695, 329; 1H-NMR (300
MHz, DMSO-d6): δ, ppm 9.12–8.44 (4H, Pc–Ar–H) 7.58–7.46 (16H, m, Pc–Ar–H and Ar–H), 7.08–7.00 (8H, m, Ar–H).
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Figure S2. IC50 graphs of complexes (1 and 2) for hCA I and hCA II isoenzymes
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